Fractions of Hoslundia opposita Vahl and hoslundin induced apoptosis in human cancer cells via mitochondrial-dependent reactive oxygen species (ROS) generation .
No Thumbnail Available
Date
2022
Authors
Ajibare, A.C.
Ebuehi, O.A.T.
Adisa, R.A.
Sofidiya, M.O.
Olugbuyiro, J.A.O.
Akinyede, K.A.
Helen Adeola Iyiola
Adegoke, Y.A.
Omoruyi, S.I.
Ekpo, O.E.
Journal Title
Journal ISSN
Volume Title
Publisher
Biomedicine & Pharmacotherapy
Abstract
Background: Cancer remains one of the leading causalities of several morbidity and mortality with negative impact on global economy due to low workforce and management/treatment cost. A number of conventional therapies have been explored in the management/treatment of cancer including chemotherapeutic intervention, radiotherapy, and surgery. Among these treatment modalities, chemotherapy remains the most popular first line of intervention in management/treatment of cancer, and natural products have been implicated as the main source of antineoplastic agents with phenomenal efficacy. However, current antineoplastic agents suffer from lack of selectivity and specificity necessitating the need for further research in the search for novel anticancer
drug molecules.
Methods: In this present study, the anticancer activity of Hoslundia opposita leaves extracts were tested against a number of cell lines including human hepatoma cell line (HepG2), human breast cancer cell lines (MDA-MB 231), intestinal epithelial cell lines (Caco-2), and human keratinocyte HACAT cell lines. A bio-guided fraction ation assay and the structural elucidation of the pure isolate (hoslundin) was conducted by 1D and 2 D NMR spectroscopy. The cell viability, colony formation, and apoptotic activities were investigated using MTT assay, clonogenic assay, and caspase − 3 and − 7 kits respectively. Flow cytometry was employed in assessing the altered cell cycle expression. The production of the intracellular reactive oxygen species (ROS) levels and the reduction of the mitochondrial membrane potential (MMP) was determined at the cellular level using fluorescent probe dyes dihydro-fluorescin diacetate (DCFH-DA) and tetramethylrhodamin (TMRE), respectively.
Results: The H. opposita fractions and its pure isolate (hoslundin) demonstrated a potent cytocidal activity against
the tumorigenic cells (HepG2, MDA-MB-231, Caco-2) at concentration ranging from 25 to 100 µg/mL. The in hibition of the colony formation was significantly observed in HepG2 cell lines. More so, the cellular viability of the normal cells (HaCaT) was relatively unchanged in the presence of H. opposita fractions and its isolate proving
the selectivity of the compounds towards tumourigenic cells. The H. opposita fractions and hoslundin exerted their anticancer activity via cell cycle arrest with the accumulation of the DNA content at the S-phase, activation of apoptosis in the caspase 3,7 activities and depolarized mitochondrial membrane potential mediated by mitochondrial-dependent ROS generation in the treated tumor cells.
Conclusion: The anticancer activities of Hoslundia opposita Vahl and hoslundin exhibited significant efficacy against tumor cells and well tolerated in the presence of normal cells making them a potential antineoplastic agent.
Description
Scholarly article
Keywords
Citation
Ajibare, A.C., Ebuehi, O.A.T.,Adisa, R.A., Sofidiya, M.O., Olugbuyiro, J.A.O., Akinyede, K.A., Omoruyi, S.I., Ekpo, O.E.,Helen Adeola Iyiola, Adegoke, Y.A., (2022). Fractions of Hoslundia opposita Vahl and hoslundin induced apoptosis in human cancer cells via mitochondrial-dependent reactive oxygen species (ROS) generation. Biomedicine & Pharmacotherapy , 153, 1-23, 113475